Key result
Five years after implantation, 43% of ICD patients had not received appropriate therapy, with primary prevention indication predicting freedom from therapy.
Observational (n=322)
Answers are grounded in this paper and cite their sources.
A significant proportion of ICD patients do not receive appropriate therapy within 5 years, but late therapies still occur, highlighting the ongoing need for device monitoring and the financial burden of unused devices.
BACKGROUND: Implantable cardioverter defibrillators (ICD's) are increasingly used for primary and secondary prevention of sudden cardiac death. However, data on how many ICD patients indeed receive appropriate ICD therapy during long-term follow-up is scarce. AIM: The aim of our study was to determine the number of patients without appropriate ICD therapy 5 years after ICD implantation, to identify predicting factors, to assess the occurrence of late first ICD therapy and to quantify the financial impact of ICD therapy in a real-world setting. DESIGN: Prospective observational study. METHODS: We prospectively enrolled 322 consecutive ICD patients. Baseline data were collected at implantation and patients were followed for a median of 7.3 years (IQR 5.8-9.2 years). Time to first appropriate ICD therapy (either antitachycardia pacing or cardioversion) was documented. RESULTS: Five years after implantation, 139 patients (43%) had not received appropriate ICD therapy. In multivariable analysis, a primary prevention indication and negative electrophysiological studies prior to ICD implantation were independent predictors of freedom from ICD therapy. Of the patients without ICD therapy, 5 years after implantation, 25% had experienced inappropriate ICD shocks. Two hundred and seven devices (1.5 devices per patient) were needed for the 139 patients without ICD intervention within 5 years, accounting for € 31,784 per patient. During an additional follow-up of 3 years, 12% of the patients with unused ICD received a late first appropriate ICD therapy. CONCLUSION: About half of the ICD patients receive appropriate ICD therapy within 5 years after implantation. Furthermore, there is a significant proportion of patients receiving late first shocks after five initially uneventful years.
No takes yet. Share an insight, caveat, or question.
Reichlin et al. (2011) conducted an observational in Implantable cardioverter-defibrillator (ICD) indication (n=322). Implantable cardioverter-defibrillator (ICD) was evaluated on Freedom from appropriate ICD therapy at 5 years. Five years after implantation, 43% of ICD patients had not received appropriate therapy, with primary prevention indication predicting freedom from therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: